The longer the stock markets are open for business, it seems like the more companies find different ways of potentially ripping of investors.
At the 20th annual Value Investing Seminar in Trani, Italy, Gabriel Grego of Quintessential Capital discussed a variety of unethical practices in the pharmaceutical industry, including falsified clinical trials and alleged stock-price manipulation.
He highlighted
Michelle deBoer-Jones is editor-in-chief of Hedge Fund Alpha. She also writes comparative analyses of stocks for TipRanks and runs Providence Writing Services. Previously, she was a television news producer for eight years, producing the morning news programs for NBC affiliates in Evansville, Indiana and Huntsville, Alabama and spending a short time at the CBS affiliate in Huntsville.
Get articles and insights from our weekly newsletter.
By entering your email, you agree to our Terms of Service and Privacy Policy.
